KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Cash from Financing Activities (2020 - 2025)

Historic Cash from Financing Activities for Organon (OGN) over the last 6 years, with Q3 2025 value amounting to -$76.0 million.

  • Organon's Cash from Financing Activities rose 256.41% to -$76.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$456.0 million, marking a year-over-year decrease of 2561.98%. This contributed to the annual value of -$368.0 million for FY2024, which is 3532.51% up from last year.
  • Per Organon's latest filing, its Cash from Financing Activities stood at -$76.0 million for Q3 2025, which was up 256.41% from -$223.0 million recorded in Q2 2025.
  • In the past 5 years, Organon's Cash from Financing Activities ranged from a high of $345.0 million in Q2 2021 and a low of -$1.1 billion during Q1 2021
  • Moreover, its 5-year median value for Cash from Financing Activities was -$82.0 million (2022), whereas its average is -$143.2 million.
  • In the last 5 years, Organon's Cash from Financing Activities soared by 15029.15% in 2021 and then crashed by 32777.78% in 2022.
  • Quarter analysis of 5 years shows Organon's Cash from Financing Activities stood at -$187.0 million in 2021, then surged by 56.15% to -$82.0 million in 2022, then rose by 6.1% to -$77.0 million in 2023, then dropped by 6.49% to -$82.0 million in 2024, then grew by 7.32% to -$76.0 million in 2025.
  • Its Cash from Financing Activities stands at -$76.0 million for Q3 2025, versus -$223.0 million for Q2 2025 and -$75.0 million for Q1 2025.